QA: Niagen Bioscience Inc in us_medicinal_products/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001386570_2014_Niagen_Bioscience_Inc.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.19181506650361885, 'aggregate_val': 8986892, 'exp_sum': 11119846, 'exp_to_value': {'AssetsCurrent': 5790699, 'AssetsNoncurrent': 2132954, 'PropertyPlantAndEquipmentNet': 1063239, 'Goodwill': 201650, 'remainder_Assets': 1931304}}

Graph

Absolute values for 0001386570, Niagen Bioscience Inc

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 2,838,134
2 remainder_Liabilities 0
3 AssetsCurrent 5,790,699
4 AssetsNoncurrent 2,132,954
5 PropertyPlantAndEquipmentNet 1,063,239
6 Goodwill 201,650
7 remainder_Assets -201,650
8 GeneralAndAdministrativeExpense 14,502,449
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 44,961
11 remainder_Revenues 10,160,964
12 remainder_NetIncome -33,079
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 2,838,134
1 Assets 8,986,892
2 Expenses 14,547,410
3 Revenues 10,160,964
4 StockholdersEquity 6,148,758
5 NetIncome -4,419,525
6 ComprehensiveNetIncome -4,419,525
7 BaseVar 18,283,240
8 EconomicCapitalRatiobeforeLimitedLiability 0.677
9 EconomicCapitalRatio 1.44

Edgar->Model Mapping

Feature Distribution

Change over Time